Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 55

Sort by

Sort Order Select

Journal Articles

Abstract 1281: Antibiotics aerosolization shrinks intratumoral Tregs and impairs lung tumor growth by perturbing the taxonomic structure of tumor-associated microbiota

Giancarla Bernardo, Valentino Le Noci, Elena Montanari, Emerenziana Ottaviano, Giorgio Gargari, Elisa Borghi, Simone Guglielmetti, Federico Ambrogi, Tiziana Triulzi, Elda Tagliabue, Serenella M. Pupa, Michele Sommariva, Lucia Sfondrini

Cancer Res (2024) 84 (6_Supplement): 1281.

https://doi.org/10.1158/1538-7445.AM2024-1281

Published: 22 March 2024

View article titled, Abstract 1281: Antibiotics aerosolization shrinks intratumoral Tregs and impairs lung tumor growth by perturbing the taxonomic structure of tumor-associated microbiota

Journal Articles

Abstract 6838: Adipose tissue features in breast cancer patients: Impact and modifications induced by tumor according to body mass index

Sandra Romero-Cordoba, Roberto Agresti, Viola Regondi, Giovanna Trecate, Francesca Bianchi, Lucia Sfondrini, Serenella M. Pupa, Elda Tagliabue, Tiziana Triulzi

Cancer Res (2024) 84 (6_Supplement): 6838.

https://doi.org/10.1158/1538-7445.AM2024-6838

Published: 22 March 2024

View article titled, Abstract 6838: Adipose tissue features in breast cancer patients: Impact and modifications induced by tumor according to body mass index

Journal Articles

ATF3 Reprograms the Bone Marrow Niche in Response to Early Breast Cancer Transformation

Milena Perrone, Claudia Chiodoni, Mara Lecchi, Laura Botti, Barbara Bassani, Annamaria Piva, Elena Jachetti, Matteo Milani, Daniele Lecis, Elda Tagliabue, Paolo Verderio, Sabina Sangaletti, Mario P. Colombo

Cancer Res (2023) 83 (1): 117–129.

https://doi.org/10.1158/0008-5472.CAN-22-0651

Published: 04 January 2023

View article titled, ATF3 Reprograms the Bone Marrow Niche in Response to Early Breast Cancer Transformation

Includes: Supplementary data

Journal Articles

Abstract 1229: miRNA and response to trastuzumab

Cancer Res (2022) 82 (12_Supplement): 1229.

https://doi.org/10.1158/1538-7445.AM2022-1229

Published: 15 June 2022

View article titled, Abstract 1229: miRNA and response to trastuzumab

Journal Articles

Abstract P5-13-26: The future of HER2-positive breast cancer patients might be written in miRNAs: An exploratory analysis from the NeoALTTO study

Cancer Res (2022) 82 (4_Supplement): P5-13-26.

https://doi.org/10.1158/1538-7445.SABCS21-P5-13-26

Published: 15 February 2022

View article titled, Abstract P5-13-26: The future of HER2-positive breast cancer patients might be written in miRNAs: An exploratory analysis from the NeoALTTO study

Journal Articles

Abstract P2-13-12: High CD36 expression predicts worse event free survival in HER2-positive breast cancer patients treated with neoadjuvant trastuzumab-based therapy: An exploratory analysis of the NeoALTTO study

Cancer Res (2022) 82 (4_Supplement): P2-13-12.

https://doi.org/10.1158/1538-7445.SABCS21-P2-13-12

Published: 15 February 2022

View article titled, Abstract P2-13-12: High CD36 expression predicts worse event free survival in HER2-positive breast cancer patients treated with neoadjuvant trastuzumab-based therapy: An exploratory analysis of the NeoALTTO study

Journal Articles

Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast Cancer

Martina Di Modica, Giorgio Gargari, Viola Regondi, Arianna Bonizzi, Stefania Arioli, Beatrice Belmonte, Loris De Cecco, Elena Fasano, Francesca Bianchi, Alessia Bertolotti, Claudio Tripodo, Laura Villani, Fabio Corsi, Simone Guglielmetti, Andrea Balsari, Tiziana Triulzi, Elda Tagliabue

Cancer Res (2021) 81 (8): 2195–2206.

https://doi.org/10.1158/0008-5472.CAN-20-1659

Published: 15 April 2021

View article titled, Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast Cancer

Includes: Supplementary data

Journal Articles

Infiltrating Mast Cell–Mediated Stimulation of Estrogen Receptor Activity in Breast Cancer Cells Promotes the Luminal Phenotype

Maria Teresa Majorini, Valeria Cancila, Alice Rigoni, Laura Botti, Matteo Dugo, Tiziana Triulzi, Loris De Cecco, Enrico Fontanella, Elena Jachetti, Elda Tagliabue, Claudia Chiodoni, Claudio Tripodo, Mario P. Colombo, Daniele Lecis

Cancer Res (2020) 80 (11): 2311–2324.

https://doi.org/10.1158/0008-5472.CAN-19-3596

Published: 02 June 2020

View article titled, Infiltrating Mast Cell–Mediated Stimulation of Estrogen Receptor Activity in Breast Cancer Cells Promotes the Luminal Phenotype

Includes: Supplementary data

Journal Articles

Abstract P3-02-01: Fatty acid uptake as a potentially new resistance mechanism to anti-HER2 treatments in HER2-positive breast cancer

Claudio Vernieri, Lorenzo Castagnoli, Francesca Ligorio, Antonino Belfiore, Elena Fasano, Paola A. Corsetto, Simona Faraci, Marta Brambilla, Francesca Corti, Tiziana Triulzi, Daniele Generali, Andrea Vingiani, Angela M. Rizzo, Giulia V. Bianchi, Giuseppe Capri, Elda Tagliabue, Filippo de Braud, Giancarlo Pruneri, Serenella M. Pupa

Cancer Res (2020) 80 (4_Supplement): P3-02-01.

https://doi.org/10.1158/1538-7445.SABCS19-P3-02-01

Published: 15 February 2020

View article titled, Abstract P3-02-01: Fatty acid uptake as a potentially new resistance mechanism to anti-HER2 treatments in HER2-positive breast cancer

Journal Articles

Abstract P4-10-32: Commensal gut microbiota influences efficacy of trastuzumab in patients with HER2-positive breast carcinoma

Elda Tagliabue, Martina Di Modica, Giorgio Gargari, Viola Regondi, Arianna Bonizzi, Stefania Arioli, Fabio Corsi, Simone Guglielmetti, Tiziana Triulzi

Cancer Res (2020) 80 (4_Supplement): P4-10-32.

https://doi.org/10.1158/1538-7445.SABCS19-P4-10-32

Published: 15 February 2020

View article titled, Abstract P4-10-32: Commensal gut microbiota influences efficacy of trastuzumab in patients with HER2-positive breast carcinoma

Journal Articles

Abstract 4959: The gut microbiota contributes to the effectiveness of HER2-targeted therapy

Martina Di Modica, Viola Regondi, Giorgio Gargari, Arianna Bonizzi, Stefania Arioli, Beatrice Belmonte, Claudio Tripodo, Simone Guglielmetti, Fabio Corsi, Tiziana Triulzi, Elda Tagliabue

Cancer Res (2019) 79 (13_Supplement): 4959.

https://doi.org/10.1158/1538-7445.AM2019-4959

Published: 01 July 2019

View article titled, Abstract 4959: The gut microbiota contributes to the effectiveness of HER2-targeted therapy

Journal Articles

Abstract 3699: Activation of NK cells cytotoxicity mediated by alveolar macrophages in the lung against murine melanoma metastases by combined aerosol immunotherapy

Michele Sommariva, Valentino Le Noci, Elda Tagliabue, Andrea Balsari, Lucia Sfondrini

Cancer Res (2017) 77 (13_Supplement): 3699.

https://doi.org/10.1158/1538-7445.AM2017-3699

Published: 01 July 2017

View article titled, Abstract 3699: Activation of NK cells cytotoxicity mediated by alveolar macrophages in the lung against murine melanoma metastases by combined aerosol immunotherapy

Journal Articles

Abstract 5428: Lactate production as a potential marker of HER2-addiction and Trastuzumab susceptibility

Lorenzo Castagnoli, Egidio Iorio, Ada Koschorke, Cristina Ghirelli, Gianmauro Palombelli, Debora Giani, Matteo Dugo, Daniele Morelli, Rossella Canese, Elda Tagliabue, Serenella M. Pupa

Cancer Res (2017) 77 (13_Supplement): 5428.

https://doi.org/10.1158/1538-7445.AM2017-5428

Published: 01 July 2017

View article titled, Abstract 5428: Lactate production as a potential marker of HER2-addiction and Trastuzumab susceptibility

Journal Articles

Abstract 5085: Cancer-associated fibroblasts transcriptional pattern reveals common changes in extracellular matrix-related genes across different cancer types

Francesca Andriani, Marta Giussani, Federica Facchinetti, Maurizio Callari, Elda Tagliabue, Ugo Pastorino, Luca Roz, Gabriella Sozzi, Gabriella Sozzi

Cancer Res (2016) 76 (14_Supplement): 5085.

https://doi.org/10.1158/1538-7445.AM2016-5085

Published: 15 July 2016

View article titled, Abstract 5085: Cancer-associated fibroblasts transcriptional pattern reveals common changes in extracellular matrix-related genes across different cancer types

Journal Articles

Abstract 748: Targeting the crosstalk between tumor cells and adipocytes to block breast cancer progression

Tiziana Triulzi, Valentina Ciravolo, Viola Regondi, Martina Di Modica, Claudia Chiodoni, Elda Tagliabue

Cancer Res (2016) 76 (14_Supplement): 748.

https://doi.org/10.1158/1538-7445.AM2016-748

Published: 15 July 2016

View article titled, Abstract 748: Targeting the crosstalk between tumor cells and adipocytes to block breast cancer progression

Journal Articles

Abstract 3826: Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast cancers

Ada Koschorke, Lorenzo Castagnoli, Gaia C. Ghedini, Tiziana Triulzi, Claudia Chiodoni, Rossella Canese, Egidio Iorio, Manuela Iezzi, Patrizia Nanni, Elda Tagliabue, Serenella M. Pupa

Cancer Res (2016) 76 (14_Supplement): 3826.

https://doi.org/10.1158/1538-7445.AM2016-3826

Published: 15 July 2016

View article titled, Abstract 3826: Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast cancers

Journal Articles

Abstract 3924: AIRE is expressed and associated with good prognosis in breast cancer

Francesca Bianchi, Loris De Cecco, Tiziana Triulzi, Sandra Romero-Cordoba, Michele Sommariva, Chiara Storti, Piera Aiello, Elda Tagliabue, Andrea Balsari, Lucia Sfondrini

Cancer Res (2016) 76 (14_Supplement): 3924.

https://doi.org/10.1158/1538-7445.AM2016-3924

Published: 15 July 2016

View article titled, Abstract 3924: AIRE is expressed and associated with good prognosis in breast cancer

Journal Articles

Abstract 1068: The promise of miR-205 in HER2+ breast cancer: predicting response to Trastuzumab and overcoming resistance

Claudia Piovan, Elvira D’Ippolito, Ilaria Plantamura, Patrizia Casalini, Elda Tagliabue, Marilena V. Iorio

Cancer Res (2016) 76 (14_Supplement): 1068.

https://doi.org/10.1158/1538-7445.AM2016-1068

Published: 15 July 2016

View article titled, Abstract 1068: The promise of miR-205 in HER2+ breast cancer: predicting response to Trastuzumab and overcoming resistance

Journal Articles

Abstract A47: A microRNA signature identifies subtypes of triple-negative breast cancer and reveals miR-342-3p as regulator of a lactate metabolic pathway through silencing monocarboxylate transporter 1

Sandra L. Romero-Cordoba, Sergio Rodriguez-Cuevas, Rosa Rebollar-Vega, Veronica Bautista-Pina, Antonio Maffuz-Aziz, Elda Tagliabue, Marilena Iorio, Elvira D'Ippolito, Sara Baroni, Ilaria Plantamura, Alfredo Hidalgo-Miranda

Cancer Res (2016) 76 (6_Supplement): A47.

https://doi.org/10.1158/1538-7445.NONRNA15-A47

Published: 13 May 2016

View article titled, Abstract A47: A microRNA signature identifies subtypes of triple-negative breast cancer and reveals miR-342-3p as regulator of a lactate metabolic pathway through silencing monocarboxylate transporter 1

Journal Articles

Abstract A18: miR-9 and miR-200 regulate PDGFRβ-mediated endothelial differentiation of neoplastic cells in triple-negative breast cancer

Elvira D'Ippolito, Ilaria Plantamura, Lucia Bongiovanni, Patrizia Casalini, Sara Baroni, Claudia Piovan, Rosaria Orlandi, Ambra V. Gualeni, Annunziata Gloghini, Anna Rossini, Filippo De Braud, Elda Tagliabue, Claudio Tripodo, Marilena V. Iorio

Cancer Res (2016) 76 (6_Supplement): A18.

https://doi.org/10.1158/1538-7445.NONRNA15-A18

Published: 13 May 2016

View article titled, Abstract A18: miR-9 and miR-200 regulate PDGFRβ-mediated endothelial differentiation of neoplastic cells in triple-negative breast cancer

NARROW

Abstract 1281: Antibiotics aerosolization shrinks intratumoral Tregs and impairs lung tumor growth by perturbing the taxonomic structure of tumor-associated microbiota

Abstract 6838: Adipose tissue features in breast cancer patients: Impact and modifications induced by tumor according to body mass index

ATF3 Reprograms the Bone Marrow Niche in Response to Early Breast Cancer Transformation

Abstract 1229: miRNA and response to trastuzumab

Abstract P5-13-26: The future of HER2-positive breast cancer patients might be written in miRNAs: An exploratory analysis from the NeoALTTO study

Abstract P2-13-12: High CD36 expression predicts worse event free survival in HER2-positive breast cancer patients treated with neoadjuvant trastuzumab-based therapy: An exploratory analysis of the NeoALTTO study

Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast Cancer

Infiltrating Mast Cell–Mediated Stimulation of Estrogen Receptor Activity in Breast Cancer Cells Promotes the Luminal Phenotype

Abstract P3-02-01: Fatty acid uptake as a potentially new resistance mechanism to anti-HER2 treatments in HER2-positive breast cancer

Abstract P4-10-32: Commensal gut microbiota influences efficacy of trastuzumab in patients with HER2-positive breast carcinoma

Abstract 4959: The gut microbiota contributes to the effectiveness of HER2-targeted therapy

Abstract 3699: Activation of NK cells cytotoxicity mediated by alveolar macrophages in the lung against murine melanoma metastases by combined aerosol immunotherapy

Abstract 5428: Lactate production as a potential marker of HER2-addiction and Trastuzumab susceptibility

Abstract 5085: Cancer-associated fibroblasts transcriptional pattern reveals common changes in extracellular matrix-related genes across different cancer types

Abstract 748: Targeting the crosstalk between tumor cells and adipocytes to block breast cancer progression

Abstract 3826: Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast cancers

Abstract 3924: AIRE is expressed and associated with good prognosis in breast cancer

Abstract 1068: The promise of miR-205 in HER2+ breast cancer: predicting response to Trastuzumab and overcoming resistance

Abstract A47: A microRNA signature identifies subtypes of triple-negative breast cancer and reveals miR-342-3p as regulator of a lactate metabolic pathway through silencing monocarboxylate transporter 1

Abstract A18: miR-9 and miR-200 regulate PDGFRβ-mediated endothelial differentiation of neoplastic cells in triple-negative breast cancer

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only